Sanofi S.A. is a French multinationalpharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50stock market index.
Sanofi was founded in 1973 as subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company. In 1993 Sanofi made a move into the Eastern Europe market by acquiring a controlling interest in Chinoin, a Hungarian drug company that had about US$104 million in sales in 1992. In that same year, Sanofi's made its first significant venture into the U.S., and strengthened its presence in Eastern Europe, by first partnering with Sterling Winthrop and then acquiring the prescription pharmaceuticals business n 1994. Sanofi was incorporated under the laws of France in 1994 as a société anonyme, a form of limited liability company.
Sanofi’s CEO on How Company Culture Can Thrive in a Distributed, Hybrid World
Paul Hudson, head of one of the world’s largest pharmaceutical companies, says leaders need to sit back and listen more often.
HBR editor in chief Adi Ignatius sat down with the Sanofi CEO to talk about how to drive a strong corporate culture in a dispersed, hybrid era; what the office of the future might look like, and companies' duty to help employees achieve their best selves. Talented employees, he says, “expect to tell you exactly what they think on any given day", and that's great.
This interview is the third in a new video series called “The New World of Work,” which will explore how top-tier executives see the future and how their companies are trying to set themselves up for success. Each week, Adi will interview a leader on LinkedIn Live — and then share an inside look at thos...
published: 11 Nov 2021
Sanofi CEO on using AI to support drug trials
Paul Hudson, CEO of Sanofi, joins 'Power Lunch' to discuss solutions-oriented approaches for the pharmaceutical industry, and implementing AI technology in clinical trials to improve the probability of a drug being successful. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning S...
published: 11 Oct 2022
Sanofi – How does mRNA work?
Learn how the body’s own protein-making machinery can be used to create new vaccines and medicines.
published: 09 May 2022
Sanofi's SVP speaks about setting up vaccine production site in Singapore
Singapore is one step closer to being an advanced manufacturing hub for pharmaceuticals. It comes on the back of an announcement that French drugmaker Sanofi is setting up a vaccine production centre here. When it is ready, the facility is tipped to be one of the most technologically advanced in the world. Vincent Hingot, Senior Vice President and Head of Global Vaccines Industrial Affairs at Sanofi Pasteur, shared more details.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsa...
published: 13 Apr 2021
Sanofi – Welcome to La Maison Sanofi
Join Sasalet Kalulu, Digital Innovation Manager at Sanofi as he takes us on a guided tour of our new headquarters.
published: 05 Jan 2023
Sanofi's new vaccine facility in Singapore to ramp up production for Asia | THE BIG STORY
0:00 - THE BIG STORY
0:53 - PHARMA GIANT SANOFI BREAKS GROUND ON $638M VACCINE FACILITY IN S'PORE
French pharmaceutical giant Sanofi broke ground on Wednesday (April 20) on its state-of-the-art vaccine facility in Singapore, which will allow it to quickly pivot to making new vaccines that might be needed to combat future pandemics. READ MORE: https://str.sg/w83z
Sanofi said its evolutive vaccine facility is the first of its kind. The fully digitalised facility can produce up to four different types of vaccines at one go, unlike current facilities around the world that can make just one at a time.
4:35 - LIVING WELL
In this week's Living Well segment, MP for Tampines GRC Baey Yam Keng, who was diagnosed with nose cancer last year, and his wife, Ms Lim Hai Yen, who suffers from aphasia, s...
published: 20 Apr 2022
Sanofi – Igniting the Potential in Everyone
Sanofi is a proud Premium Partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further and to never, ever settle as we chase the miracles of science to improve people’s lives. We overcome setbacks to keep moving forward not just for ourselves but for our patients, colleagues, families and friends.
Paul Hudson, head of one of the world’s largest pharmaceutical companies, says leaders need to sit back and listen more often.
HBR editor in chief Adi Ignatius...
Paul Hudson, CEO of Sanofi, joins 'Power Lunch' to discuss solutions-oriented approaches for the pharmaceutical industry, and implementing AI technology in clin...
Paul Hudson, CEO of Sanofi, joins 'Power Lunch' to discuss solutions-oriented approaches for the pharmaceutical industry, and implementing AI technology in clinical trials to improve the probability of a drug being successful. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Paul Hudson, CEO of Sanofi, joins 'Power Lunch' to discuss solutions-oriented approaches for the pharmaceutical industry, and implementing AI technology in clinical trials to improve the probability of a drug being successful. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Singapore is one step closer to being an advanced manufacturing hub for pharmaceuticals. It comes on the back of an announcement that French drugmaker Sanofi is...
Singapore is one step closer to being an advanced manufacturing hub for pharmaceuticals. It comes on the back of an announcement that French drugmaker Sanofi is setting up a vaccine production centre here. When it is ready, the facility is tipped to be one of the most technologically advanced in the world. Vincent Hingot, Senior Vice President and Head of Global Vaccines Industrial Affairs at Sanofi Pasteur, shared more details.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
Singapore is one step closer to being an advanced manufacturing hub for pharmaceuticals. It comes on the back of an announcement that French drugmaker Sanofi is setting up a vaccine production centre here. When it is ready, the facility is tipped to be one of the most technologically advanced in the world. Vincent Hingot, Senior Vice President and Head of Global Vaccines Industrial Affairs at Sanofi Pasteur, shared more details.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
0:00 - THE BIG STORY
0:53 - PHARMA GIANT SANOFI BREAKS GROUND ON $638M VACCINE FACILITY IN S'PORE
French pharmaceutical giant Sanofi broke ground on Wednesday ...
0:00 - THE BIG STORY
0:53 - PHARMA GIANT SANOFI BREAKS GROUND ON $638M VACCINE FACILITY IN S'PORE
French pharmaceutical giant Sanofi broke ground on Wednesday (April 20) on its state-of-the-art vaccine facility in Singapore, which will allow it to quickly pivot to making new vaccines that might be needed to combat future pandemics. READ MORE: https://str.sg/w83z
Sanofi said its evolutive vaccine facility is the first of its kind. The fully digitalised facility can produce up to four different types of vaccines at one go, unlike current facilities around the world that can make just one at a time.
4:35 - LIVING WELL
In this week's Living Well segment, MP for Tampines GRC Baey Yam Keng, who was diagnosed with nose cancer last year, and his wife, Ms Lim Hai Yen, who suffers from aphasia, share with The Big Story on how they have coped with their illnesses. https://str.sg/w8JL
18:10 - FASTER, TECH-ENABLED CARGO CLEARANCE AT TUAS PORT
In other headlines, cargo vehicle drivers now have a faster journey at Tuas Port while undergoing clearance checks as the Immigration and Checkpoints Authority prepares the port to handle larger volumes of cargo. https://str.sg/w83V
Journalist Jessie Lim talks about what this means for consumers.
#thebigstory #vaccine #sanofi
SUBSCRIBE ➤ http://bit.ly/FollowST
Turn on notifications 🔔 to stay updated
--------------------
WEBSITE ➤ http://www.straitstimes.com
TELEGRAM ➤ https://t.me/TheStraitsTimes
FACEBOOK ➤ https://www.facebook.com/TheStraitsTimes
TIKTOK ➤ https://www.tiktok.com/@straitstimes
INSTAGRAM ➤ https://www.instagram.com/straits_times
TWITTER ➤ https://twitter.com/straits_times
PODCASTS ➤ http://str.sg/stpodcasts
#STLive #lawrencewong #leehsienloong #PAP #Singapore
0:00 - THE BIG STORY
0:53 - PHARMA GIANT SANOFI BREAKS GROUND ON $638M VACCINE FACILITY IN S'PORE
French pharmaceutical giant Sanofi broke ground on Wednesday (April 20) on its state-of-the-art vaccine facility in Singapore, which will allow it to quickly pivot to making new vaccines that might be needed to combat future pandemics. READ MORE: https://str.sg/w83z
Sanofi said its evolutive vaccine facility is the first of its kind. The fully digitalised facility can produce up to four different types of vaccines at one go, unlike current facilities around the world that can make just one at a time.
4:35 - LIVING WELL
In this week's Living Well segment, MP for Tampines GRC Baey Yam Keng, who was diagnosed with nose cancer last year, and his wife, Ms Lim Hai Yen, who suffers from aphasia, share with The Big Story on how they have coped with their illnesses. https://str.sg/w8JL
18:10 - FASTER, TECH-ENABLED CARGO CLEARANCE AT TUAS PORT
In other headlines, cargo vehicle drivers now have a faster journey at Tuas Port while undergoing clearance checks as the Immigration and Checkpoints Authority prepares the port to handle larger volumes of cargo. https://str.sg/w83V
Journalist Jessie Lim talks about what this means for consumers.
#thebigstory #vaccine #sanofi
SUBSCRIBE ➤ http://bit.ly/FollowST
Turn on notifications 🔔 to stay updated
--------------------
WEBSITE ➤ http://www.straitstimes.com
TELEGRAM ➤ https://t.me/TheStraitsTimes
FACEBOOK ➤ https://www.facebook.com/TheStraitsTimes
TIKTOK ➤ https://www.tiktok.com/@straitstimes
INSTAGRAM ➤ https://www.instagram.com/straits_times
TWITTER ➤ https://twitter.com/straits_times
PODCASTS ➤ http://str.sg/stpodcasts
#STLive #lawrencewong #leehsienloong #PAP #Singapore
Sanofi is a proud Premium Partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go furth...
Sanofi is a proud Premium Partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further and to never, ever settle as we chase the miracles of science to improve people’s lives. We overcome setbacks to keep moving forward not just for ourselves but for our patients, colleagues, families and friends.
Sanofi is a proud Premium Partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further and to never, ever settle as we chase the miracles of science to improve people’s lives. We overcome setbacks to keep moving forward not just for ourselves but for our patients, colleagues, families and friends.
Paul Hudson, CEO of Sanofi, joins 'Power Lunch' to discuss solutions-oriented approaches for the pharmaceutical industry, and implementing AI technology in clinical trials to improve the probability of a drug being successful. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Singapore is one step closer to being an advanced manufacturing hub for pharmaceuticals. It comes on the back of an announcement that French drugmaker Sanofi is setting up a vaccine production centre here. When it is ready, the facility is tipped to be one of the most technologically advanced in the world. Vincent Hingot, Senior Vice President and Head of Global Vaccines Industrial Affairs at Sanofi Pasteur, shared more details.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
0:00 - THE BIG STORY
0:53 - PHARMA GIANT SANOFI BREAKS GROUND ON $638M VACCINE FACILITY IN S'PORE
French pharmaceutical giant Sanofi broke ground on Wednesday (April 20) on its state-of-the-art vaccine facility in Singapore, which will allow it to quickly pivot to making new vaccines that might be needed to combat future pandemics. READ MORE: https://str.sg/w83z
Sanofi said its evolutive vaccine facility is the first of its kind. The fully digitalised facility can produce up to four different types of vaccines at one go, unlike current facilities around the world that can make just one at a time.
4:35 - LIVING WELL
In this week's Living Well segment, MP for Tampines GRC Baey Yam Keng, who was diagnosed with nose cancer last year, and his wife, Ms Lim Hai Yen, who suffers from aphasia, share with The Big Story on how they have coped with their illnesses. https://str.sg/w8JL
18:10 - FASTER, TECH-ENABLED CARGO CLEARANCE AT TUAS PORT
In other headlines, cargo vehicle drivers now have a faster journey at Tuas Port while undergoing clearance checks as the Immigration and Checkpoints Authority prepares the port to handle larger volumes of cargo. https://str.sg/w83V
Journalist Jessie Lim talks about what this means for consumers.
#thebigstory #vaccine #sanofi
SUBSCRIBE ➤ http://bit.ly/FollowST
Turn on notifications 🔔 to stay updated
--------------------
WEBSITE ➤ http://www.straitstimes.com
TELEGRAM ➤ https://t.me/TheStraitsTimes
FACEBOOK ➤ https://www.facebook.com/TheStraitsTimes
TIKTOK ➤ https://www.tiktok.com/@straitstimes
INSTAGRAM ➤ https://www.instagram.com/straits_times
TWITTER ➤ https://twitter.com/straits_times
PODCASTS ➤ http://str.sg/stpodcasts
#STLive #lawrencewong #leehsienloong #PAP #Singapore
Sanofi is a proud Premium Partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further and to never, ever settle as we chase the miracles of science to improve people’s lives. We overcome setbacks to keep moving forward not just for ourselves but for our patients, colleagues, families and friends.
Sanofi S.A. is a French multinationalpharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50stock market index.
Sanofi was founded in 1973 as subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company. In 1993 Sanofi made a move into the Eastern Europe market by acquiring a controlling interest in Chinoin, a Hungarian drug company that had about US$104 million in sales in 1992. In that same year, Sanofi's made its first significant venture into the U.S., and strengthened its presence in Eastern Europe, by first partnering with Sterling Winthrop and then acquiring the prescription pharmaceuticals business n 1994. Sanofi was incorporated under the laws of France in 1994 as a société anonyme, a form of limited liability company.